35th Anniversary Annual Meeting & Pre-Conference Programs (SITC 2020)

Starts:  Nov 10, 2020 8:00 AM (ET)
Ends:  Nov 15, 2020 12:00 PM (ET)

The Society for Immunotherapy of Cancer’s (SITC) 35th Anniversary Annual Meeting & Pre-Conference Programs (SITC 2020) will be reimagined as a fully VIRTUAL experience this year to ensure the health and safety of program attendees and their patients, and in celebration of the society’s 35th anniversary, all SITC members are invited to register for FREE!

Registration and other details will be announced soon!

Important Dates

  • April 1 – Regular abstracts, Young Investigator Award abstracts, late-breaking abstract applications and Immunotherapy Resistance and Failure Pre-Conference Program presentation application submission open
  • April 20 – General attendee registration open
  • July 31 – Regular abstracts, Young Investigator Award abstracts, late-breaking abstract applications and Immunotherapy Resistance and Failure Pre-Conference Program presentation application submission close
  • Aug. 21 – Late-Breaking Abstract submission period open 
  • Sept. 4 – Branding and advertising commitment deadline 
  • Sept. 11 – Late-Breaking Abstract submission period close
  • Oct. 26 – Pre-registration mailing lists available
  • Nov. 30 – Post-Annual Meeting mailing lists available

Thank You to Our Organizers

Annual Program Committee CHAIR

Sandra Demaria, MD – Weill Cornell Medicine

35th Anniversary Annual Meeting Organizers

Helen E. Heslop, MD – Baylor College of Medicine
Brianna W. Hoffner, MSN, ANP-BC, AOCNP – Harborside
Miriam Merad, MD, PhD – Icahn School of Medicine at Mount Sinai
Padmanee Sharma, MD, PhD – The University of Texas MD Anderson Cancer Center
Jedd D. Wolchok, MD, PhD – Memorial Sloan Kettering Cancer Center

35th Anniversary Annual Meeting Program Committee Members

Ana Carrizosa Anderson, PhD – Harvard Medical School
Davide Bedognetti, MD, PhD – Sidra Medicine
Marianne Davies, DNP, AOCNP – Yale School of Nursing
Patrick Hwu, MD – The University of Texas MD Anderson Cancer Center

Immunotherapy Resistance and Failure

Kald Abdallah, MD, PhD – Bristol-Myers Squibb
Edward Cha, MD, PhD – Genentech
Jennifer Gansert, MD, PhD – Amgen 
Israel Lowy, MD, PhD – Regeneron Pharmaceuticals
Giovanni Melillo, MD – AstraZeneca
Eric Rubin, MD – Merck & Co., Inc.

Primer on tumor immunology and cancer Immunotherapy™ Organizers

Michael A. Curran, PhD – The University of Texas MD Anderson Cancer Center
Yvonne Saenger, MD – Columbia University Irving Medical Center

workshop on engineering immune cells for cancer therapy

Christine Brown, PhD – City of Hope
Katayoun Rezvani, MD, PhD – The University of Texas MD Anderson Cancer Center
Marco Ruella, MD – University of Pennsylvania

Grant writing workshop

David Aggen, MD, PhD – Memorial Sloan Kettering Cancer Center
Olivia Rongze Lu, PhD – University of Texas at Austin
Claire Vanpouille-Box, PhD – Weill Cornell Medical College
Grey Wilkinson, PhD – Oncolytics Biotech Inc.

Keynotes Announced

Keynote address: Turning immunologically quiescent tumors into immune responsive cancers

Elizabeth M. Jaffee, MD – Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

35th Anniversary Keynote: t cell therapy of cancer

Helen E. Heslop, MD – Baylor College of Medicine

richard v. smalley, md, memorial award and lectureship

Lieping Chen, MD, PhD – Yale Cancer Center
Gordon Freeman, PhD – Dana-Farber Cancer Institute
Arlene Sharpe, MD, PhD – Harvard Medical School



View the SITC Meeting Code of Conduct.


#CME
#CNE
#CPE
#Advanced
#Foundational
#Intermediate
#InPersonEvent
#AnnualMeeting
#AlliedHealth
#Clinician
#Industry
#RegisteredNurse
#Oncologist
#PatientAdvocate
#Pharmacist
#PrimaryCarePhysician
#Researcher

Location

Online Instructions:
Url: http://www.sitcancer.org/2020/home
Login: Registration and other details will be announced soon!

Contact